MetaCap

Sotera Health Financial Ratios

NASDAQ: SHCHealth CareMisc Health and Biotechnology ServicesUSD

18.06+0.23 (+1.29%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Sotera Health ratio analysis

Sotera Health earned a net margin of 6.7% in FY 2025, up from 4.0% a year earlier. Gross margin was 55.5% compared with a median of 54.9% over the prior 6 years. Return on equity reached 12.9%, meaning Sotera Health generated 0.13 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 3.53 versus 5.49 the year before, and the current ratio was 2.46. At the end of FY 2025, SHC traded at 65.5 times earnings; across the 4 fiscal years shown, its year-end P/E ranged from 57.4 to 93.6, with a median of 75.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Sotera Health financial ratios (annual)

Sotera Health annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
P/E ratio (at fiscal year end)65.5285.1993.61—57.44——
Price / sales4.323.504.512.327.067.97—
Price / book8.299.5210.676.6611.2214.42—
Gross margin55.5%54.7%55.0%55.5%55.7%54.2%50.8%
Operating margin—27.0%26.4%24.7%27.6%25.2%23.6%
Net margin6.7%4.0%4.9%-23.3%12.5%-4.7%-2.7%
Free cash flow margin12.8%4.1%-34.6%9.5%19.3%8.2%11.8%
Return on equity (ROE)12.9%11.0%11.6%-66.7%19.9%-8.5%—
Return on assets (ROA)2.4%1.4%1.6%-7.5%4.2%-1.4%—
Debt / equity3.535.495.025.552.974.03—
Current ratio2.462.752.420.812.152.24—
Revenue growth5.7%4.9%4.5%7.8%13.9%5.1%—
EPS growth68.8%-11.1%—-302.4%———

Related